Other OTC - Delayed Quote USD

EOM Pharmaceuticals Holdings, Inc. (IMUC)

0.1979 0.0000 (0.00%)
As of April 22 at 11:08 AM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Irach B. Taraporewala B.S., M.S., Ph.D. CEO, President & Director 265.65k -- 1956
Mr. Wayne I. Danson CPA CFO & Treasurer 150k -- 1954
Mr. Eli Goldberger Founder, Chairman & COO -- -- 1990
Dr. Shalom Z. Hirschman M.D. Co-Founder, Chief Scientific Officer & Medical Director -- -- 1936

EOM Pharmaceuticals Holdings, Inc.

136 Summit Avenue
Montvale, NJ 07645
United States
201 351 0605 https://www.eompharma.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
3

Description

Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. Immunocellular Therapeutics, Ltd. was founded in 2020 and is headquartered in Montvale, New Jersey.

Corporate Governance

EOM Pharmaceuticals Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Related Tickers

SIGY Sigyn Therapeutics, Inc.
5.75
0.00%
 
ATRX Adhera Therapeutics, Inc.
0.0089
+18.83%
 
IVBXF Innovent Biologics, Inc.
4.8900
0.00%
 
ATBPF Antibe Therapeutics Inc.
0.2156
0.00%
 
IPCIF Intellipharmaceutics International Inc.
0.0600
0.00%
 
NBIO Nascent Biotech, Inc.
0.0999
0.00%
 
WXIBF WuXi Biologics (Cayman) Inc.
1.6450
0.00%
 
TTNP Titan Pharmaceuticals, Inc.
6.98
-1.06%
 
CDT Conduit Pharmaceuticals Inc.
3.1000
-1.90%
 
OBIO Orchestra BioMed Holdings, Inc.
4.5000
+1.35%